SCHEMBL8823669

SCHEMBL8823669

CONc1ccccc1F

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ HPGD P15428 2/20 0.46
▸ L3MBTL1 Q9Y468 2/20 0.46
▸ SMN1; SMN2 Q16637 5/20 0.45
▸ RAB9A P51151 5/20 0.45
▸ NPC1 O15118 3/20 0.45
▸ PSIP1 O75475 1/20 0.44
▸ ALDH1A1 P00352 2/20 0.43
▸ GAA P10253 1/20 0.43
▸ NFKB1 P19838 2/20 0.42
▸ NFKB2 Q00653 2/20 0.42
▸ RELA Q04206 2/20 0.42
▸ MEN1 O00255 1/20 0.42
▸ KMT2A Q03164 1/20 0.42
▸ PKM P14618 1/20 0.42
▸ PDK1 Q15118 1/20 0.42
▸ PDK2 Q15119 1/20 0.42
▸ PDK3 Q15120 1/20 0.42
▸ PDK4 Q16654 1/20 0.42
▸ MAPT P10636 2/20 0.41
▸ KDM4E B2RXH2 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29791345 0.76 PDK1 (0.46) HPGDL3MBTL1SMN1; SMN2RAB9ANPC1
SCHEMBL1430242 0.73 MAPT (0.50) HPGDSMN1; SMN2RAB9ANPC1ALDH1A1
SCHEMBL307353 0.72 — —
SCHEMBL30662726 0.72 — —
SCHEMBL20040913 0.72 LTA4H (0.46) HPGDSMN1; SMN2ALDH1A1MEN1KMT2A
SCHEMBL14106778 0.71 CA1 (0.55) HPGDL3MBTL1SMN1; SMN2RAB9ANPC1
SCHEMBL10625640 0.71 MAPT (0.46) HPGDL3MBTL1SMN1; SMN2RAB9ANPC1
SCHEMBL1189820 0.71 PDE4D (0.44) HPGDRAB9ANPC1ALDH1A1MEN1
SCHEMBL2356967 0.71 MAPT (0.48) HPGDL3MBTL1SMN1; SMN2RAB9AALDH1A1
SCHEMBL8075826 0.71 RAB9A (0.45) HPGDSMN1; SMN2RAB9ANPC1PSIP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2021094974-A1 HETEROCYCLIC TRPML1 AGONISTS LIBRA THERAPEUTICS, INC. (US) 2021-05-20 — — WO disclosed
US-8455252-B2 Materials and methods for sensitizing multidrug resistant cells INDIANA UNIVERSITY RESEARCH AND TECHNOLOGY CORP. (US) 2013-06-04 — — US disclosed
US-5656658-A Method for the treatment of anxiety ASTRA AKTIEBOLAG (SE) 1997-08-12 — — US disclosed
US-5646309-A Intermediates in the synthesis of chroman derivatives ASTRA AKTIEBOLAG (SE) 1997-07-08 — — US disclosed
US-5639772-A Chroman derivatives ASTRA AKTIEBOLAG (SE) 1997-06-17 — — US disclosed
US-5639784-A ADMINISTERING 3-AMINO-5-CARBAMOYL-CHROMENES AND DERIVATIVES ASTRA AKTIEBOLAG (SE) 1997-06-17 — — US disclosed
Send feedback